[Nifuratel application in treating patients with Giardia, combined with intestinal dysbiosis].
M A
MA
Sheviakov
A V
AV
Sobolev
O A
OA
Shurpitskaia
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005873:Giardiasis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009545:Nifuratel / Q000008:administration & dosage*; D012189:Retrospective Studies
D000935:Antifungal Agents; D009545:Nifuratel